Sin conexión a internet: se muestra la versión guardada de la página.

Silence Therapeut…

USUSD
← Al screener

Silence Therapeutics PLC (US:SLNCF) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 1. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
silence-therapeutics.com
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede central
LONDON, United Kingdom
Consejero delegado
Iain Gladstone Ross
Empleados
88
Acciones en circulación
141.74 M a 2026-07-31
Capital flotante
37.84 M
Capitalización bursátil
665.67 M USD
Insiders
7.97%
Inversores institucionales
39.68%
Industria (SIC)
Pharmaceutical Preparations
FCF
−42.3 M USD
Deuda
0
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
Descripción

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksSLNCFUSD3.85 -3.75%acciones ordinarias

Precio en 3 meses

US:SLNCF · USD
día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Noticias de esta semana

Aún no hay noticias del sitio web de la empresa.

anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
Siren, L.L.C.5.5%3.31 M2026-06-30
TCG Crossover Management…5.04%3.03 M2026-06-30
Redmile Group, LLC3.6%2.16 M2026-06-30
Nantahala Capital Manage…2.24%1.35 M2026-06-30
Citadel Advisors Llc2.21%1.33 M2026-06-30
Nextech Invest, Ltd.1.58%952 4002026-06-30
Millennium Management Ll…1.51%909 2792026-06-30
Ikarian Capital, LLC1.38%830 7842026-06-30
Tetragon Partners GP Ltd…1.27%764 2562026-06-30
Soleus Capital Managemen…1.05%630 0002026-06-30
Fidelity Advisor Series…0.8%482 0882026-07-31
iShares Trust-iShares Bi…0.39%234 0092026-08-31
ALGER FUNDS-Alger Small…0.18%105 6792026-07-31
Fidelity Select Portfoli…0.17%103 9122026-07-31
ALGER INSTITUTIONAL FUND…0.07%41 2922026-07-31
Fidelity Concord Street…0.05%29 5382026-07-31
SPDR INDEX SHARES Fd.S-S…0.02%9 5322026-06-30
Trust for Professional M…0.01%8 6952026-05-31
Steward Funds Inc-Stewar…0.01%5 8002026-07-31
Invesco Exchange-Traded…0%2 9182026-08-31